We also treated HCT116 cells with ATRA, an inhibitor of Pin1 activity and expression (Wei et al., 2015) that has been used as potential cancer therapeutic agent (Nakatsu et al., 2018; Yang et al., 2018; Zhang et al., 2019). This evidence concerns the gene PIN1 and cancer.